News

This researcher’s project joins at least 30 others across the University of California system that have been terminated by ...
New research reveals that the immune checkpoint molecule Tim-3 plays a critical role in how microglia, the brain’s immune cells, respond to Alzheimer’s disease.
The American Civil Liberties Union also filed a lawsuit last week, alleging that the federal agency and its parent department ...
Scientists have discovered a new protein pathway involved in neurodegeneration by studying “mini-brain” organoids made from patients with frontotemporal lobar degeneration (FTLD).
Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's disease (AD), but its role in the brain was unknown until now. Researchers used ...
Weight training may help protect the brains of older adults from dementia, including those already showing signs of mild ...
GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.
A simpler method of analyzing blood samples for Alzheimer's disease has been tested in a large multicenter study led by Lund ...
The woman’s brain was donated to research after her death, and it was analyzed by researchers for signs of Alzheimer’s ...
A dementia caregiver should be mindful of personality and behavior changes to best anticipate the patient’s needs. Find ...
Quest Diagnostics (DGX) launched a new laboratory blood test designed to help physicians confirm amyloid brain pathology due to Alzheimer’s ...
An extended study after a primary trial supports using the anti-amyloid drug lecanemab (Leqembi) for up to 36 months in ...